MorphoSys EUR 115 million Capital Increase, Germany
2016
STJ Advisors advised MorphoSys AG, the German biotechnology company involved in the development of research and antibodies, on their capital increase via an accelerated bookbuild offering, raising proceeds of EUR 115 million.